Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Graft Engineering for allogeneic hematopoietic stem cell transplantation (HSCT) and modified donor lymphocyte infusion (DLI)

Closed Survey/Study

Cellular Therapy & Immunobiology Working Party (CTIWP)

Type de traitement

Investigateur principal

Moniek de Witte

Trends in non sibling donor in HSCT CR2

Retrospective Studies

Acute Leukemia Working Party (ALWP)

Type de traitement

Allogeneic - Haploidentical

Investigateur principal

Trends in donor characteristics for unrelated Stem Cell Transplantation in patients with acute myeloid leukemia

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Leukemia Working Party (ALWP)

Type de traitement

Investigateur principal

Haploidentical versus matched sibling donors hematopoietic stem cell transplantation for adult patients with relapsed/refractory acute lymphoblastic leukemia

Retrospective Studies

Acute Lymphatic Leukaemia (ALL)

Acute Leukemia Working Party (ALWP)

Type de traitement

Allogeneic - Haploidentical

Investigateur principal

Trends in allogeneic stem cell transplantation (HSCT) over two decades in patients with secondary acute myelogenous leukemia (sAML) being transplanted from sibling (MSD) or unrelated donors (UD). A Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.

Retrospective Studies

Acute Myeloid Leukaemia (AML)

Acute Leukemia Working Party (ALWP)

Type de traitement

Investigateur principal

Impact of Specific Adverse Cytogenetic Features on Outcomes after Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome with Very Poor Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of EBMT

Retrospective Studies

Myelodysplastic (MDS) or MDS/MPN

Chronic Malignancies Working Party (CMWP)

Type de traitement

Investigateur principal

Impact de caractéristiques cytogénétiques défavorables spécifiques sur les résultats après allogreffe de cellules hématopoïétiques dans le syndrome myélodysplasique avec cytogénétique de très mauvais pronostic : une étude du Chronic Malignancies Working Party de l'EBMT

Études rétrospectives

Syndrome Myélodysplasique (MDS) ou MDS/MPN

Chronic Malignancies Working Party (CMWP)

Type de traitement

Investigateur principal

Prevention and management of conditioning related skin toxicity in paediatric HSCT patients

Closed Survey/Study

Nursing Research Committee

Nursing Paediatric Committee

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Mihaela Hartmann, Hilda Mekelenkamp

Prévention et gestion de la toxicité cutanée liée à la préparation chez les patients pédiatriques en greffe de cellules souches hématopoïétiques (HSCT)

Toutes les maladies

Nursing Research Committee

Nursing Paediatric Committee

Paediatric Diseases Working Party (PDWP)

Type de traitement

Investigateur principal

Mihaela Hartmann, Hilda Mekelenkamp

Machine Learning grading system for acute graft-versus host disease

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Steroid refractory acute graft-versus-host disease - survey

Transplant Complications Working Party (TCWP)

Type de traitement

Investigateur principal

Renal failure in aplastic anemia

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type de traitement

Investigateur principal

Beatrice Drexler